Header Logo

Benjamin Bovell-Ammon

Concepts (50)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prisoners
5
2026
179
1.900
 Why?
Substance Abuse, Intravenous
3
2026
83
1.790
 Why?
Narcotic Antagonists
5
2026
133
1.570
 Why?
Opioid-Related Disorders
6
2026
528
1.530
 Why?
Opiate Substitution Treatment
5
2026
223
1.430
 Why?
HIV Infections
4
2026
955
1.260
 Why?
Naltrexone
6
2026
91
1.080
 Why?
Buprenorphine
4
2025
198
0.910
 Why?
Buprenorphine, Naloxone Drug Combination
3
2026
26
0.670
 Why?
Mortality
1
2021
161
0.650
 Why?
Mental Health
1
2023
361
0.610
 Why?
Quality of Life
1
2023
1260
0.450
 Why?
Substance-Related Disorders
1
2022
755
0.440
 Why?
Methadone
3
2025
140
0.440
 Why?
Substance Withdrawal Syndrome
2
2026
126
0.420
 Why?
Cohort Studies
3
2024
2620
0.390
 Why?
Prisons
2
2024
120
0.340
 Why?
Adult
7
2026
17358
0.300
 Why?
Cross-Sectional Studies
3
2026
2701
0.280
 Why?
Male
9
2026
31047
0.280
 Why?
Longitudinal Studies
2
2023
1282
0.280
 Why?
Female
9
2026
34018
0.270
 Why?
Comparative Effectiveness Research
2
2026
46
0.270
 Why?
Retrospective Studies
4
2024
6872
0.260
 Why?
Russia
2
2023
56
0.240
 Why?
Humans
12
2026
65140
0.230
 Why?
Boston
1
2026
258
0.220
 Why?
Massachusetts
3
2026
2145
0.220
 Why?
Proportional Hazards Models
2
2025
740
0.200
 Why?
Anti-Retroviral Agents
1
2022
76
0.180
 Why?
Young Adult
2
2023
4809
0.180
 Why?
Adolescent
2
2023
6297
0.170
 Why?
Delayed-Action Preparations
3
2026
120
0.160
 Why?
Middle Aged
4
2026
18273
0.160
 Why?
Analgesics, Opioid
1
2025
527
0.160
 Why?
United States
1
2021
8093
0.070
 Why?
Treatment Outcome
2
2026
5792
0.050
 Why?
Needle Sharing
1
2023
14
0.050
 Why?
Observational Studies as Topic
1
2024
66
0.050
 Why?
Naloxone
1
2024
53
0.050
 Why?
Program Evaluation
1
2025
493
0.050
 Why?
Social Stigma
1
2023
78
0.050
 Why?
Risk-Taking
1
2023
159
0.050
 Why?
Pilot Projects
1
2025
1015
0.040
 Why?
Randomized Controlled Trials as Topic
1
2025
805
0.040
 Why?
Research Design
1
2024
588
0.040
 Why?
Texas
1
2020
59
0.040
 Why?
Risk Assessment
1
2025
2102
0.030
 Why?
Hospitalization
1
2025
1392
0.030
 Why?
Risk Factors
1
2020
5429
0.020
 Why?
Bovell-Ammon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (50)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_